Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon Injection for Postoperative Analgesia in Thoracoscopic Lung Surgery
NCT07810413Not yet recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Sep 2026
- Primary completion
- Dec 2026
01
Overview
Randomised, double-blind trial of hsk21542 in postoperative pain (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Sum of Pain Intensity Difference over 24 Hours. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07810413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07810413.